Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Days Sales Outstanding

: 201.27 (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

Shandong Weigao Group Medical Polymer Co's average Accounts Receivable for the six months ended in Jun. 2023 was $1,062 Mil. Shandong Weigao Group Medical Polymer Co's Revenue for the six months ended in Jun. 2023 was $963 Mil. Hence, Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the six months ended in Jun. 2023 was 201.27.

The historical rank and industry rank for Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding or its related term are showing as below:

SHWGY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 118.67 Med: 139.84 Max: 207.25
Current: 207.25

During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest Days Sales Outstanding was 207.25. The lowest was 118.67. And the median was 139.84.

SHWGY's Days Sales Outstanding is ranked worse than
93.45% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 63.91 vs SHWGY: 207.25

Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding increased from Jun. 2022 (173.42) to Jun. 2023 (201.27).

Shandong Weigao Group Medical Polymer Co Days Sales Outstanding Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

130.31

129.75

146.27

183.98

201.70

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding																142.81	173.42	201.60	201.27	220.18

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Weigao Group Medical Polymer Co Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding falls into.

Shandong Weigao Group Medical Polymer Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (953.041	+	1016.261)	/	2 )	/	1953.47	*	365
=	984.651					/	1953.47	*	365
=	183.98

Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (1016.261	+	1108.169)	/	2 )	/	963.178	*	365 / 2
=	1062.215					/	963.178	*	365 / 2
=	201.27

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shandong Weigao Group Medical Polymer Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019